Forensic pharmaceutical analysis of counterfeit medicines
The World Health Organisation suggests that falsified and substandard medicines (FSMs) constitute approximately 10% of medicines globally with higher figures expected in low and middle income countries (LMICs). To combat the proliferation of FSMs, this study is aimed at developing simple and rapid i...
Main Author: | Ogwu, John |
---|---|
Published: |
De Montfort University
2018
|
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.768234 |
Similar Items
-
Combating Substandard and Counterfeit Medicines by Securing the Pharmaceutical Supply Chain:
by: Phuong Chi Nam Sophie Le, et al.
Published: (2018-07-01) -
Analysis of judicial and pharmaceutical practice concerning falsification of medicines and circulation of counterfeit medicines
by: Остап Богданович Панькевич, et al.
Published: (2016-08-01) -
Pharmaceutical Serialization, a Global Effort to Combat Counterfeit Medicines
by: Pascu Georgiana Andreea, et al.
Published: (2020-12-01) -
Study of Forensic Examinations of Counterfeit Whisky
by: Hsun Mi, et al.
Published: (1020) -
Counterfeit Medicines in Socioeconomic Perspective
by: Desy Nuryunarsih Nuryunarsih
Published: (2017-05-01)